International Stem Cell CORP (ISCO) stock

ISCOOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 1/30

$0.28+0.00 (+0.89%)

Close on Oct 19, 2026Market cap $2.27MP/E –Yield –

International Stem Cell EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

International Stem Cell's EV/EBITDA was 0.5× on Jan 30, 2026.

Period	Period end	Value	Change (pts)
2026	Jan 30, 2026	0.5×	+0.0
2025	Dec 31, 2025	0.5×	−14.9
2023	Apr 28, 2023	15.4×	–

Parsed from the XBRL in International Stem Cell's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-150 reverse split on Jul 29, 2015
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing